Introduction {#s1}
============

The unique vascular topology of different organs exists for organ-specific functions. Different vascular network densities determine the specific amount of oxygen and nutrients to be delivered to each host tissue. Development of new vascular networks depends upon two types of specialized endothelial cells that work together: (1) The endothelial \'tip cell\', which is located at the front of a growing vessel and guides its extension by sensing and responding to environmental cues, analogous to the axonal growth cone ([@bib13]; [@bib22]). (2) \'Stalk cells\', which trail behind the tip cell and elongate the sprout. Tip and stalk cell identities are primarily controlled by the Dll4-Notch lateral inhibition pathway, which is activated in endothelial cells in response to VEGF from the local environment. VEGF-induced Dll4 activates Notch1 on the neighboring cell, leading to the down-regulation of VEGF receptor levels ([Figure 1B](#fig1){ref-type="fig"}) ([@bib18]; [@bib23]; [@bib24]; [@bib31]),([@bib4]; [@bib28]; [@bib29]). Thus, lateral inhibition between endothelial cells generates an alternating pattern of active tip cells (Dll4 high) and inhibited stalk cells (Dll4 low). Moreover, tip cell selection is a dynamic process, and tip cell identity is transient ([@bib2]; [@bib19]). Reiteration of tip cell selection, sprout extension, and connection of neighboring sprouts (anastomosis) is the basis for building a sophisticated vascular network ([@bib1]; [@bib10]). Although this VEGF/Notch signaling pathway has been well studied and found to be conserved among different vascular beds and species, how this central pattern generator is modified by various target tissue-specific signals to yield diverse network topologies is not known.10.7554/eLife.13212.003Figure 1.Calibrated computational model predicts delayed tip cell selection in the absence of Sema3E-Plexin-D1 signaling.(**A**) Whole-mount vascular staining (Isolectin B4) of retinas from *Sema3e^-/-^* and wildtype littermates at P4. The mutant vasculature exhibits a reduced number of tip cells and branching points (asterisks) and an uneven growth front (arrows and arrowheads). Scale bar: 500 μm. (**B**) Feedback between the VEGF/Notch and Sema3E-Plexin-D1 signaling pathways included in the extended agent-based computational model of tip cell selection. D1-D4: transcriptional delays. r1-r3: recovery delays representing degradation. δ, s, σ: change in expression levels in response to receptor activation. (**C**) Simulated tip cell selection. Colors represent Dll4 levels on a continuum from purple (low) to green (high). The red boxes highlight a time frame in which a salt and pepper pattern has formed in the control vessel, while in the absence of Sema3E-Plexin-D1 signaling, only few early tip cells have been selected. (**D**) Average number of selected tip cells in simulated vessels. At a timepoint where the simulated control vessel (black line) already exhibits an alternating pattern of tip and stalk cells, the simulated vessel lacking Sema3E-Plexin-D1 signaling (blue line, for a given set of parameter values: δ =5, s=3) shows a 50% reduction in tip cells. Thin lines: standard deviation. n=50. (**E**) In silico Dll4 levels in single endothelial cells during simulated tip cell selection. In the control situation (top), Dll4 levels quickly stabilize. In the absence of Sema3E-Plexin-D1 signaling (bottom) Dll4 levels fluctuate in near synchrony before they finally stabilize.**DOI:** [http://dx.doi.org/10.7554/eLife.13212.003](10.7554/eLife.13212.003)

Here, we propose a general principle of how collective cell behavior determines the diverse densities of different networks: the generation of vascular topologies depends heavily on the *temporal* regulation of tip cell selection. Integrated simulations predict that as cell neighborhoods change, due to anastomosis or cell rearrangement events, lateral inhibition patterns will necessarily be disrupted, requiring continual re-selection of new tip cells ([@bib8]; [@bib5]). In fact, mouse genetics experiments demonstrated that tip cell numbers are positively correlated with the branching points of the network ([@bib18]; [@bib21]). Therefore, the *length of time* it takes to establish (and re-establish) the alternating pattern of tip and stalk cells may be a missing, critical determinant of vascular topology ([@bib7]; [@bib9]). Here, we took an integrated approach combining computational modeling, mouse genetics, and in vivo endothelial cell tracking to determine whether tip/stalk patterning can be temporally modulated to generate different topologies. We hypothesize that the frequency of tip cell selection determines the length of linear extension vs. branching, thus dictating the density of the network.

To begin to test this hypothesis, it is crucial to analyze dynamic single cell behavior and collective movement in the context of network formation ([@bib2]; [@bib19]). Previously, we used static analyses of the postnatal mouse retina as a model to understand how neural signals shape vascular topology ([@bib21]). We discovered that retina ganglion cell-derived Semaphorin3E (Sema3E) and its receptor Plexin-D1, which is expressed in endothelial cells at the front of actively sprouting blood vessels, control the VEGF/Notch pathway via a feedback mechanism. Mice lacking either Sema3E or Plexin-D1 exhibited an uneven vascular growth front and a reduction of tip cells that resulted in a less branched network compared to their wildtype littermate controls ([@bib21]) ([Figure 1A](#fig1){ref-type="fig"}). However, it is not clear how this phenotype is generated: specifically, how the Sema3E-Plexin-D1 feedback mechanism regulates VEGF/Notch signaling at a dynamic cellular level, and whether changes in temporal modulation of this pathway lead to the overall vascular topology phenotype.

To begin to understand how Sema3E-Plexin-D1 signaling modifies vascular topology formation in a dynamic, spatiotemporal manner, we took advantage of an existing agent-based computational model (the \'MemAgent-Spring Model\' or MSM) that simulates the cellular processes during tip cell selection making explicit the time it takes for gene expression (e.g. transcription/translation) changes to occur ([Figure 1B,C](#fig1){ref-type="fig"} -- note time delay parameters D1 and D2) ([@bib6]; [@bib8]). The MSM has been tested against numerous independent experimental data sets and validated as predictive of new mechanisms in vivo/in vitro ([@bib5]; [@bib17]; [@bib19]). To now simulate tip cell selection in the context of Sema3E-Plexin-D1 crosstalk signaling with VEGF/Notch signaling ([@bib12]; [@bib21]) the MSM model was extended by adding four new parameters ([Figure 1B](#fig1){ref-type="fig"}, [Video 1](#media1){ref-type="other"}--[5](#media5){ref-type="other"}), with sensitivity analyses and calibration simulations performed, which include modulation of the existing parameter (δ) representing the induction level of Dll4 by VEGFR-2 activation (See methods section). These four new parameters represent the time delay for induction of Plexin-D1 by VEGF (D3), the time delay (D4) and strength (s) of the reduction of Dll4 levels in response to Sema3E-Plexin-D1 signaling, based on the experimental data previously shown ([@bib21]), as well as the degradation rate of Plexin-D1 (r3). Loss of Sema3E-PlexinD1 signaling was simulated by setting all Plexin-D1 levels to zero. Loss of function simulations recapitulated the two prominent features of *Plxnd1^-/-^* and *Sema3e^-/-^* mutant retinal vasculature remarkably closely: In vivo, mutant vascular networks exhibit fewer tip cells and 1.5--2 fold reduction in branching points, as well as an uneven growth front (compare [Figure 1A](#fig1){ref-type="fig"} with 1C \[red boxes\]) ([@bib21]). Furthermore, the dynamic nature of the simulations provided a novel insight to explain how this phenotype is generated. Simulations predict that higher Dll4 levels in the cells generates a shift towards synchronized Dll4 fluctuations overtime in contiguous cells, as they collectively battle more strongly via lateral inhibition negative feedback, causing an overall delay in amplification of differences needed to select the alternating pattern of tip and stalk cells ([Figure 1C--E](#fig1){ref-type="fig"}, [Video 6](#media6){ref-type="other"},[7](#media7){ref-type="other"}). Therefore, computational simulations suggest that Sema3E-Plexin-D1 signaling enhances the speed and frequency of tip cell selection and thus increases the density of retinal vascular networks.Video 1.Calibration of time delay parameters (induction of Plexin-D1, reduction of Dll4 levels).Simulation of tip cell selection with Sema3E-Plexin-D1 related regulatory time delays equal to the time it takes for pVEGFR-2 to up-regulate Dll4 (D3+D4=D1). Color indicates cell Dll4 levels (green = high, purple = low).**DOI:** [http://dx.doi.org/10.7554/eLife.13212.004](10.7554/eLife.13212.004)10.7554/eLife.13212.004Video 2.Calibration of time delay parameters (induction of Plexin-D1, reduction of Dll4 levels).Simulation of tip cell selection with Sema3E-Plexin-D1 related regulatory time delays slightly slower than the time it takes for pVEGFR-2 to up-regulate Dll4 (D3+D4=D1+1). Dll4 levels flash irregularly between very high and very low with no stable selection possible. Color indicates cell Dll4 levels (green = high, purple = low).**DOI:** [http://dx.doi.org/10.7554/eLife.13212.005](10.7554/eLife.13212.005)10.7554/eLife.13212.005Video 3.Calibration of time delay parameters (induction of Plexin-D1, reduction of Dll4 levels).Simulation of tip cell selection with Sema3E-Plexin-D1 related regulatory time delays slightly faster than the time it takes for pVEGFR-2 to up-regulate Dll4 (D3+D4=D1-1). Dll4 levels flash irregularly between very high and very low with no stable selection possible. Color indicates cell Dll4 levels (green = high, purple = low).**DOI:** [http://dx.doi.org/10.7554/eLife.13212.006](10.7554/eLife.13212.006)10.7554/eLife.13212.006Video 4.Calibration of Plexin-D1 degradation rate.Simulation of tip cell selection with slowed degradation of Plexin-D1 allowing it to affect transcription of Dll4 for one timestep (12 s) longer. Dll4 levels flash irregularly between very high and very low with no stable selection possible. Color indicates cell Dll4 levels (green = high, purple = low).**DOI:** [http://dx.doi.org/10.7554/eLife.13212.007](10.7554/eLife.13212.007)10.7554/eLife.13212.007Video 5.Calibration of Plexin-D1 degradation rate.Simulation of tip cell selection with slowed degradation of Plexin-D1 allowing it to affect transcription of Dll4 for two timesteps (30 s) longer. Dll4 levels flash irregularly between very high and very low with no stable selection possible. Color indicates cell Dll4 levels (green = high, purple = low).**DOI:** [http://dx.doi.org/10.7554/eLife.13212.008](10.7554/eLife.13212.008)10.7554/eLife.13212.008Video 6.Simulation of a vessel with 20 endothelial cells in the absence of Sema3E-Plexin-D1 signaling.Extended regions occur with no sprouting as cells battle for longer undergoing fluctuations as the Dll4 up-regulation is higher. These eventually resolve and tip cells are selected across the whole region.**DOI:** [http://dx.doi.org/10.7554/eLife.13212.009](10.7554/eLife.13212.009)10.7554/eLife.13212.009Video 7.Simulation of a wildtype vessel for comparison with [Video 6](#media6){ref-type="other"}.The selection occurs much faster and more regularly than in the vessel without Sema3E-Plexin-D1 signaling.**DOI:** [http://dx.doi.org/10.7554/eLife.13212.010](10.7554/eLife.13212.010)10.7554/eLife.13212.010

We next examined single cell behavior in a mosaic environment, because lateral inhibition requires collective coordination, and the relative, not absolute, levels of Dll4 expression among neighboring cells determine the outcome of the tip cell selection process ([@bib19]). A *Plxnd1^-/-^* cell will behave differently in competition with a second *Plxnd1^-/-^* cell than in competition with a wildtype cell. Thus, we investigated whether the cell autonomous function of Sema3E-Plexin-D1 signaling in the direct competition process between two neighboring endothelial cells can drive changes to the tip cell selection dynamics. In a simulated mosaic vessel, where cells lacking Sema3E-Plexin-D1 signaling are intermingled with normal cells, the contribution of cells lacking Sema3E-Plexin-D1 signaling to the tip cell population was predicted to increase to 68--74% (robustly across a range of parameter values: δ =4--6, s=2--4) in comparison to control cells ([Figure 2A,B](#fig2){ref-type="fig"}, [Video 8](#media8){ref-type="other"}), with an increased speed of patterning compared to a vessel entirely lacking Sema3E-Plexin-D1 signaling. This result suggests that normally, Plexin-D1 cell-autonomously suppresses the tip cell phenotype.10.7554/eLife.13212.011Figure 2.Sema3E-PlexinD1 signaling is cell-autonomously required to suppress tip cell identity.(**A**) Simulated tip cell selection in a mosaic vessel with 50% mutant cells placed randomly. Cells without Sema3E-Plexin-D1 signaling are indicated by bright pink color, which turns to yellow if Dll4 levels increase. For wildtype cells: purple = low Dll4, pink = high Dll4. (**B**) Comparison of simulated and in vivo contribution to the tip cell population by cells lacking Sema3E-Plexin-D1 signaling at 45% mosaicism. A range of δ values simulates different strengths of loss of Sema3E-Plexin-D1 signaling. Simulations, n=50, in vivo, n=6. Data is represented as mean +/- SEM. (**C**) Analysis of the occupation of tip or stalk cell position by *Plxnd1* expressing wildtype cells in control retina (left), and *Plxnd1^-/-^* cells (middle) or GFP+ cells (right) in mosaic retinas at P5. Red: vascular membrane staining (Isolectin B4), blue: vascular nuclear staining (α-ERG), green: in situhybridization (left, middle), α-GFP staining (right). (**D**) Quantification of c. n.s.= not significant, \*\*p=0.0033. WT retinas, n=6; *Plxnd1^-/-^*mosaic retinas, n=6; GFP+ mosaic retinas, n=4. Scale bar: 50 μm. Data is represented as mean +/- SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.13212.011](10.7554/eLife.13212.011)Video 8.Simulated mosaic vessel with 50% mutant cells placed randomly.Cells without Sema3E-Plexin-D1 signaling are indicated by bright pink color, which turns to yellow if Dll4 levels increase. For wildtype cells: purple = low Dll4, pink = high Dll4 as before. This chimera achieves a 75% contribution of mutant cells to the tip.**DOI:** [http://dx.doi.org/10.7554/eLife.13212.012](10.7554/eLife.13212.012)10.7554/eLife.13212.012

To test the direct competition of *Plxnd1^-/-^* cells and wildtype cells in vivo, we performed mosaic analysis using mice with tamoxifen inducible loss of *Plxnd1* expression in the vasculature (*Cdh5-Cre-ER^T2^; Plxnd1^flox/flox^*). In the sprouting front of the wildtype retina, cells expressing Plexin-D1 were equally distributed at both tip cell and the adjacent stalk cell positions ([Figure 2C](#fig2){ref-type="fig"}, left panel, [Figure 2D](#fig2){ref-type="fig"}), showing they have no preference for either position. However, at approximately 45% of *Plxnd1^-/-^* mosaicism, 75% of the *Plxnd1^-/-^* cells became tip cells ([Figure 2C](#fig2){ref-type="fig"}, middle panel, [Figure 2D](#fig2){ref-type="fig"}) indicating that these cells do have a competitive advantage over Plexin-D1 expressing wildtype cells during tip cell selection. In contrast, in control experiments using mice with tamoxifen inducible expression of GFP (*Cdh5-Cre-ER^T2^; Z/EG^+^*), GFP positive cells showed no preference for either position ([Figure 2C](#fig2){ref-type="fig"}, right panel, [Figure 2D](#fig2){ref-type="fig"}), demonstrating that preferential tip cell occupancy of mutant cells is due to lack of Sema3E-Plexin-D1 signaling. Taken together, in silico prediction and in vivo mosaic retinal analyses demonstrate that Sema3E-Plexin-D1 signaling suppresses the tip cell phenotype in a cell-autonomous manner. Interestingly, this cell-autonomous effect at single cell level contrasts with the effect of Sema3E-Plexin-D1 signaling at the collective level, where more new tip cells are selected in the presence than in the absence of Sema3E-Plexin-D1 signaling ([Figure 1](#fig1){ref-type="fig"}). This finding highlights the differences between collective and cell autonomous behaviors, and the challenge of intuiting one from the other.

Having confirmed that the calibrated set of parameters is valid to model contributions of the Sema3E-Plexin-D1 pathway to VEGF/Notch patterning and to predict new in vivo data of a static nature, we next employed the model to predict the effect of Sema3E-Plexin-D1 signaling on the rate of tip cell selection during the fuller dynamic network formation processes in which tip and stalk cell identities are constantly re-defined during cell rearrangement/position switching. Here, we used a new \'MSM-CPM\' model that has been previously extended, parameterized and experimentally validated to simulate tip/stalk patterning together with cellular rearrangements within a vascular sprout ([@bib5]). In this model, a cell can move within the adhered collective of the sprout powered by multiple local junctional movements. By incorporating the newly calibrated Sema3E-PlexinD1 signaling extension the MSM-CPM model we simulated cell rearrangements in vascular sprouts in the presence or absence of Sema3E-Plexin-D1 signaling ([Figure 3A,B](#fig3){ref-type="fig"}, [Video 9](#media9){ref-type="other"},[10](#media10){ref-type="other"}). Simulations predicted that in the presence of Sema3E-Plexin-D1 signaling, the tip cell is repeatedly overtaken by another cell. In contrast, in the absence of Sema3E-Plexin-D1 signaling, tip cell overtaking frequency is reduced by factor of 1.26; a given tip cell occupies the tip cell position for a longer time ([Figure 3C](#fig3){ref-type="fig"}). Given the MSM is a qualitative not quantitative model we also performed simulations over a range of parameters and found that if the strength of Dll4 upregulation by VEGF (δ) is increased then this delay in overtaking is further exaggerated; a given tip cell occupies the tip cell position longer ([Figure 3C](#fig3){ref-type="fig"}).10.7554/eLife.13212.013Figure 3.Computational simulation predicts that lack of Sema3E-Plexin-D1 signaling leads to prolonged tip cell occupancy and reduced tip cell overtaking frequency.(**A**) Single frames of cell rearrangements in simulated sprouts of 10 cells. VEGF gradient extends in direction of vessel. (**B**) Kymograph plots of cell rearrangements in simulated sprouts. Each line represents one endothelial cell. Arrows indicate overtaking events at the tip cell position in a and b. (**C**) Quantification of overtaking events at the tip cell position in the presence and absence of Sema3E-Plexin-D1 signaling. A range of δ values simulates different strengths of loss of Sema3E-Plexin-D1 signaling. The setting δ=5, which matched loss of Sema3E-Plexin-D1 signaling in other conditions in the paper exhibits a 1.26 slower tip cell overtaking frequency (events/hour.) As δ increases there is a clear trend towards slower tip cell overtaking across δ values. Data is presented as mean +/- SD, n=50.**DOI:** [http://dx.doi.org/10.7554/eLife.13212.013](10.7554/eLife.13212.013)Video 9.Simulation of normal cell rearrangement and tip cell overtaking in a sprout consisting of ten cells, two per vessel cross section.VEGF gradient extends in the direction of the sprout. Each cell indicated by a different color.**DOI:** [http://dx.doi.org/10.7554/eLife.13212.014](10.7554/eLife.13212.014)10.7554/eLife.13212.014Video 10.Simulation of cell rearrangement in a sprout, in the absence of Sema3E-Plexin-D1, consisting of ten cells, two per vessel cross-section.VEGF gradient extends in the direction of the sprout. Each cell indicated by a different color.**DOI:** [http://dx.doi.org/10.7554/eLife.13212.015](10.7554/eLife.13212.015)10.7554/eLife.13212.015

To test experimentally if tip cell selection and overtaking rates are slowed down in the absence of Sema3E-Plexin-D1 signaling, we next performed live endothelial cell tracking to follow the behavior of individual cells in an actively forming vascular network. Previously, live imaging with single cell resolution has mainly been described in sprouting assays using aortic rings ([@bib2]) or embryoid bodies (EBs) generated from ES cells ([@bib19]). However, those assays primarily give rise to simple linear sprouts with less frequent branching than observed during retinal angiogenesis. To better mimic in vivo temporal and spatial events within a highly branched network, we developed a new ex vivo system, using explants from embryonic lungs. Whole embryonic lungs (E12.0) were embedded within a collagen matrix in a tissue culture dish containing medium supplemented with recombinant human VEGF. After one day, endothelial sprouts grow out of the explant ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}) with tip cells extending filopodia into the collagen matrix ([Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}). We observed branching events at various positions of the sprouts ([Figure 4B](#fig4){ref-type="fig"}), as well as anastomosis ([Figure 4---figure supplement 1C](#fig4s1){ref-type="fig"}), showing that all steps of the in vivo angiogenic sprouting process are recapitulated in our system even though there is no gradient of VEGF signaling. Lung explants endogenously express *Sema3e* and *Plxnd1* ([Figure 4---figure supplement 1D](#fig4s1){ref-type="fig"}). We could also detect Plexin-D1 and Dll4 in sprouting endothelial cells ([Figure 4---figure supplement 1E,F](#fig4s1){ref-type="fig"}). We next performed long-term live imaging of wildtype and *Plxnd1^-/-^* explants and analyzed tip cell selection frequency. In contrast to the computational model where a tip cell selection event can only occur via a switch between two cells at the tip of the sprout ([Figure 3A](#fig3){ref-type="fig"}), in the live imaging assay, tip cell selection events occur in the following distinct categories ([Figure 4A,B](#fig4){ref-type="fig"}): a positional switch between a tip and a stalk cell in a linear sprout (switch), the selection of a new tip cell at the front of the sprout (branch, type I) or at more proximal sites (branch, type II). Single cells were tracked manually using a nuclear live stain. Consistent with the computational model prediction, in vivo live imaging data indeed showed a significant delay in the selection of new tip cells in *Plxnd1^-/-^* vascular sprouts compared to wildtype sprouts. The overall appearance of new tip cells, i.e. the tip cell selection frequency, was slowed down by factor 1.5 in the mutants ([Figure 4C,D](#fig4){ref-type="fig"}, [Video 11,12](#media11){ref-type="other"}). When analyzing the different categories separately, the number of events per total imaging time was significantly reduced in the categories \'switch\' and \'branch, type II\' in the absence of Sema3E-Plexin-D1 signaling ([Figure 4E](#fig4){ref-type="fig"}).10.7554/eLife.13212.016Figure 4.Endothelial cell live tracking in ex vivo lung explants reveals a reduction in tip cell selection frequency and a less branched lung vascular network in the absence of Sema3E-Plexin-D1 signaling.(**A**) Different types of tip cell selection events observed during live imaging. (**B**) Single frames from live imaging experiments illustrating the different types of tip cell selection events. Arrowheads point out the newly selected tip cells. Nuclei: blue. Scale bar: 50 μm. (**C**) Long-term live imaging experiments of vascular sprouts from wildtype and *Plxnd1^-/-^* lung explants. Single planes from z-stacks are shown. Arrowheads indicate a tip cell selection event. Nuclei: blue (top and middle), white (bottom). Individual nuclei are outlined by different colors in the middle panel. (**D**) Quantification of tip cell selection frequency calculated as events per hour. Tip cell selection frequency is reduced by factor 1.5 in sprouts from *Plxnd1^-/-^* explants. WT, n=24 sprouts from 12 explants. *Plxnd1^-/-^*, n=30 sprouts from 11 explants. Data is represented as mean +/- SEM. (**E**) Quantification of tip cell selection frequency calculated as incidence of events in each category as illustrated in (**A**) during total imaging time. \*\*p=0.013 (**D**), \*p=0.029 (e 'switch'), 0.041 (e 'branch, type II'), permutation test with shuffled genotypes. (**F**) Vascular sprouts originating from *Plxnd1^+/-^* and *Plxnd1^-/-^* lung explants on day 3. Left: whole-mount vascular staining (green, PECAM), right: reconstructed/skeletonized network, Scale bar: 250 μm. (**G**) Quantification of branching points per area. The number of branching points is significantly reduced in *Plxnd1^-/-^* lung explants. Data is represented as mean +/- SEM. *Plxnd1^+/-^*, n=7 explants; *Plxnd1^-/-^*, n=6 explants. \*\*\*p=0.0005, permutation test with shuffled genotypes.**DOI:** [http://dx.doi.org/10.7554/eLife.13212.016](10.7554/eLife.13212.016)10.7554/eLife.13212.017Figure 4---figure supplement 1.The ex vivo sprouting assay.(**A**) Sprouts originating from the lung explant express endothelial specific marker PECAM. Explants at day 1 (left) and day 3 (right) are shown. Scale bar: 300 μm. (**B**) Tip cells extend filopodia (arrows) into the collagen matrix. Scale bar: 50 μm. (**C**) Anastomosis: a new connection (arrow) is formed between neighboring sprouts. Scale bar: 50 μm (**D**) *Sema3e* and *Plxnd1* are expressed by embryonic lung explants as shown by RT PCR. (**E**) Sprouting endothelial cells express Plexin-D1 (green). PECAM staining shown in red. Scale bar: 10 µm. (**F**) In wildtype endothelial sprout Dll4 (green) localized in the tip cells (arrow). Dll4-positive area is increased in *Plxnd1^-/-^* explants. Scale bar: 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.13212.017](10.7554/eLife.13212.017)10.7554/eLife.13212.018Figure 4---figure supplement 2.Computational method used for vascular network analysis.The region of interest (ROI) was defined as the vascular network originating from the lung explants. Vasculature inside the lung tissue was excluded from the analysis. Stacks of confocal images were binarized and then skeletonized by thinning. Branching points were identified as skeleton pixels with at least three neighbors and quantified to characterize the vascular network. The 2D images shown are the maximum intensity z-projections of the original 3D stacks, except for the binary image, which is an intensity sum z-projection.**DOI:** [http://dx.doi.org/10.7554/eLife.13212.018](10.7554/eLife.13212.018)10.7554/eLife.13212.019Figure 4---figure supplement 3.Model: Modifications of the central pattern generator lead to the formation of diverse vascular topologies.The unique topologies of organ-specific vascular networks are dependent on the tight temporal control of the tip cell selection process. The VEGF-Notch lateral inhibition pathway is the central pattern generator of tip cell selection. We suggest that in different tissues, specific target-derived signals functioning as \'molecular metronomes\' regulate the pace of the pattern generator to ensure the formation of networks that cater each tissue's specific need. A \'fast molecular metronome\' (e.g. Sema3E-Plexin-D1 signaling) will speed up the Dll4/Notch feedback loop and increase the frequency of tip cell selection, leading to the formation of a dense network with a small pore size, while a \'slow molecular metronome\' will slow down the Dll4/Notch feedback loop and decrease the tip cell selection frequency, resulting in a network with larger pore sizes.**DOI:** [http://dx.doi.org/10.7554/eLife.13212.019](10.7554/eLife.13212.019)Video 11.Wildtype sprout in ex vivo endothelial cell tracking assay.The movie represents 9 hr of live imaging and corresponds to [Figure 4C](#fig4){ref-type="fig"}, left panel. Merge of fluorescent channel (nuclear live stain) and brightfield channel. Arrows indicate newly selected tip cells that give rise to a new sprout. Arrowhead indicates a switching event. Single planes from z-stacks are shown.**DOI:** [http://dx.doi.org/10.7554/eLife.13212.020](10.7554/eLife.13212.020)10.7554/eLife.13212.020Video 12.*Plxnd1^-/-^* sprout in ex vivo endothelial cell tracking assay.The movie represents 9 hr of live imaging and corresponds to [Figure 4C](#fig4){ref-type="fig"}, right panel. Merge of fluorescent channel (nuclear live stain) and brightfield channel. Arrows indicate newly selected tip cells that give rise to a new sprout. Single planes from z-stacks are shown.**DOI:** [http://dx.doi.org/10.7554/eLife.13212.021](10.7554/eLife.13212.021)10.7554/eLife.13212.021

Finally, to directly test experimentally whether the reduced tip cell selection rate observed by live imaging in our *Plxnd1^-/-^* lung explant indeed leads to a less branched network over time, we analyzed the topology of the lung explant under the same culture conditions as the live imaging paradigm. Using a computational method ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"} and detailed description in the material and methods section) to analyze the number of branching points in an unbiased way we found a significant reduction in branching points of the network ([Figure 4F,G](#fig4){ref-type="fig"}). These data further demonstrate that a slowed tip cell selection rate results in a less branched vascular network.

Together, the ex vivo and in silico results demonstrate that Sema3E-Plexin-D1 signaling modulate the pace of tip cell selection. In the absence of Sema3E-Plexin-D1 signaling, the rate of tip cell selection is reduced, which overall leads to longer linear sprout extension with less frequent branching substantially influencing the architecture of the growing vasculature and resulting in a less dense network, as seen in the *Plxnd1* and *Sema3e* mutant lung explant as well as in retina ([@bib21]).

During angiogenesis, the topology of the network is shaped essentially through the dynamic process of stalk cells turning into a new tip cell (tip cell selection), which is dependent on the Delta-Notch lateral inhibition pathway, a widely used machinery to regulate aspects of development that require temporal control by a \'molecular clock\'. For example, during somitogenesis, Delta-Notch oscillations determine the frequency of new somite formation (\'the somite clock\') ([@bib3]). In endothelial cells, we propose that modulation of any of the components of the central pattern generator will result in an altered pace of Delta-notch oscillations and an altered vascular patterning. Deceleration of the Delta-notch feedback loop (by a \'slow molecular metronome\') will lead to the selection of fewer tip cells within a certain time frame and thus to the formation of a less dense network with bigger pore sizes. Acceleration of the selection process (by a \'fast molecular metronome\') would result in an overly dense network ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}). However, complex nonlinear feedback dynamics are often hard to intuit, and further careful simulation integrated with experimentation will be required to fully elucidate the temporal modulations and topological outcomes possible.

In this work, we describe how Sema3E-Plexin-D1 signaling can modify vascular density by impinging on the central pattern generator VEGF/Notch signaling. Our computational modeling predictions, mouse genetics mosaic analysis, and live imaging of individual cell dynamics in actively forming blood vessel networks and computational quantification of branching points show that the lack of Sema3E-Plexin-D1 signaling slows down the rate of tip cell selection and rearrangement, resulting in a less branched vascular network. Therefore, the Sema3E-Plexin-D1 pathway represents a \'faster molecular metronome\' that results in a relatively dense network. These data suggest that *temporal* regulation of this critical, iterative aspect of network formation could be a general mechanism, and additional temporal regulators with varying pace (fast vs. slow) may exist to sculpt vascular topology in different tissues. Furthermore, our findings may provide insights into our understanding of morphogenesis in general, and aid in efforts to develop therapeutic approaches for tissue engineering and control of tumor progression and vascular diseases.

Material and methods {#s2}
====================

Animals {#s2-1}
-------

*Plxnd1^flox/flox^*mice ([@bib33]), *Plxnd1^+/-^* mice ([@bib16]) and *Cdh5-Cre-ER^T2^*mice ([@bib25]) were maintained on a C57Bl/6 background. *Z/EG+* reporter ([@bib26]) mice were maintained on a 129P3J;C57Bl/6 mixed background. Pregnant mice were obtained following overnight mating (day of vaginal plug was defined as embryonic day 0.5). All animals were treated according to institutional and US National Institutes of Health (NIH) guidelines approved by the Institutional Animal Care and Use Committee (IACUC) at Harvard Medical School.

Mosaic retina analysis {#s2-2}
----------------------

Cre-mediated recombination was induced by intraperitoneal injection of tamoxifen (T5648, Sigma-Aldrich) dissolved in safflower oil on postnatal day (P) 4. Due to the different Cre sensitivities at *Plxnd1* and Z/EG locus, we experimentally determined the dosage of tamoxifen necessary for 45% of mosaicism. 25 pg of tamoxifen was injected in Cdh5*-Cre-ER^T2^; Plxnd1^flox/flox^*pups, and 10 ng of tamoxifen was injected in *Cdh5-Cre-ER^T2^; Z/EG+* pups. Mice were sacrificed at P5 and retinas were isolated for analysis. In situ hybridization, Isolectin B4 staining and ERG immunohistochemistry (1:200; SC353, Santa Cruz) were performed as described previously. Images of flat mounted retinas were taken at 40x magnification using Zeiss LSM 510 META confocal microscope. Images were processed using Adobe Photoshop and Image J (National Institutes of Health). Mosaic recombination in *Cdh5-Cre-ER^T2^;Plxnd1^flox/flox^*or *Z/EG; Cdh5-Cre-ER^T2^*was analyzed by in situ signal or GFP positivity, respectively, in combination with Isolectin B4 and endothelial nuclear ERG staining. The tip cells were determined as blind-ended endothelial cells that are associated with filopodia protrusions at the sprouting front. Endothelial cells (either tip or stalk cells) were counted by combination of Erg positive staining and morphological definition. 84 endothelial cells from 3 *Cdh5-Cre-ER^T2^;Plxnd1^flox/flox^*animals and 64 endothelial cells from 3 wildtype animals were counted for tip cells and stalk cells that were either *Plxnd1* positive or negative. 37 endothelial cells from 2 *Z/EG;Cdh5-Cre-ER^T2^*animals were counted for tip cells and stalk cells that were either GFP positive or negative. Statistical significance was tested using two-way Anova.

RT-PCR {#s2-3}
------

Total RNA was extracted from collagen embedded lung explants, or whole retina using the RNeasy Micro Plus RNA extraction kit (Qiagen) according to manufacturer's instructions. cDNA was generated from 100 ng total RNA using the Superscript III reverse transcription kit (Invitrogen). The following primers were used to detect *Plxnd1* and *Sema3e* transcripts: *Sema3e* forward 5'-aggctacgcctgtcacataaa-3', *Sema3e* reverse 5'-ccgttcttgatactcatccagc-3'; *Plxnd1* forward 5'-gctgactgtagcctatgggga-3',*Plxnd1* reverse 5'- gccatctggtgggatgtcat-3'.

Ex vivo endothelial cell tracking assay {#s2-4}
---------------------------------------

Lungs were dissected from E12.0 embryos in ice-cold dissecting medium (DMEM + Penicillin/Streptomycin), divided into single lobes, washed in dissecting medium (30 min, 4°C) and embedded in a glass-bottom dish (Mattek) between two layers of polymerized collagen IA gel (1.5 mg/ml, Cellmatrix) prepared as previously described([@bib20]). After solidification of collagen (30 min, 37°C), imaging medium was added (DMEM without phenol red, 15% ES cell grade FBS, 30 ng/ml rhVEGF (R&D systems), antibiotics). Explants were grown overnight at 37°C, 5% CO~2~. Next day, nuclear live stain solution (NucBlue, Life Technologies, Carlsbad, CA) was added (2 drops/ml for 45 min). Imaging medium was replaced and explants were imaged immediately using a Leica SP8 confocal microscope equipped with a Tokai Hit chamber (37°C, 5% CO~2~). 70 μm stacks were acquired at 20x magnification every 10 min. Single cells were tracked manually using a combination of nuclear staining and bright-field images of the sprouts. Per explant, 1--4 sprouts were analyzed for 9--20 hr. Tip cell selection frequency was calculated as selection events observed per hour live imaging. All 3 types of tip cell selection events were considered for quantification of selection frequency. Statistical significance was tested using a permutation test with shuffled genotypes.

Immunostaining of lung explants {#s2-5}
-------------------------------

Explants were dissected at E12.0 or E13.5, prepared as described above, and fixed on day 2 or 3 in 4% PFA for 1 hr at RT. Then they were washed in PBS (3 x 10 min), permeabilized in blocking solution (PBS + 2% BSA + 0.2% Triton) for 1 hr at RT (2 x 30 min) and incubated with PECAM (1:300, BD), Plexin-D1 (abcam) or Dll4 (R&D) primary antibody in PBS + 0.2% Triton overnight at 4°C and additional 6 hrs at RT. Explants were then washed in PBS + 0.1% Triton (6x 30 min), incubated with secondary antibody in PBS + 0.1% Triton overnight at 4°C and washed in PBS + 0.1% Triton (2 x 30 min). If HRP-conjugated secondary antibody was used, explants were washed longer (3 x 30 min in PBS) and stained with DAB staining solution (1 mg/ml Diaminobenzindine tetrahydrochloride in PBS, Sigma) for 3 min. For network topology analysis, Alexa488 conjugated secondary antibody was used and explants were imaged at a Leica SP8 confocal microscope at 10x magnification.

Computational modeling {#s2-6}
----------------------

In the previously established \'MemAgent-Spring Model\' (MSM) each endothelial cell is comprised of multiple smaller computational elements (\'agents\') that represent local sections of cell membrane and actin tension beneath. The memAgents have dynamic internal levels of proteins, which enable them to sense protein levels in the local extracellular environment (primarily VEGF ligands). The endothelial cell integrates this local spatial information to determine its behavior (e.g. extension of filopodia) and perform genetic regulatory processes (e.g. Dll4-Notch) after a time delay representing the processes of transcription and translation (parameters D1 and D2 in [Figure 1B](#fig1){ref-type="fig"}). As the time delay for Notch/VEGF gene expression is not currently known in the mouse, the model was calibrated to match the known Notch periodicity (30 min) of the zebrafish somite clock ([@bib14]) so D1=D2=28 time steps (representing 7 min of real time) as it was previously shown that, consistent with period/delay relations in the Notch somite clock models ([@bib14]), the periodicity of Notch/VEGF signaling in the MSM model = 2 x (D1+D2+R1+R2), where R1 and R2 are the recovery delays, representing degradation rates, which were both set to 1 ([@bib6]).

To include Sema3E-Plexin-D1 interactions to the existing MSM model of VEGF/Notch/Dll4 signaling in endothelial cells during tip/stalk selection (full model described in \[[@bib6]; [@bib8]\]), four new parameters were included. Two new time delay parameters: D3 controls how long it takes for VEGFR-2 to increase Plexin-D1 protein levels at the membrane and D4 determines the time it takes for an active Plexin-D1 receptor to lower Dll4 expression. Additionally *s* was added to determine the strength of Plexin-D1 down-regulation of Dll4 (specifically how many fewer Dll4 are produced for one active Plexin-D1 receptor) and *r3*, which controls how long the down regulation effect lasts for, encompassing the factors such as Plexin-D1 degradation rate, see [Figure 1B](#fig1){ref-type="fig"} for schematic.

As Sema3E is assumed to be uniformly present around the cell based on experimental data in the mouse retina ([@bib21]), activation of Plexin-D1 by Sema3E is not directly modeled, but simply assumed to occur at a constant level. As the exact number of Plexin-D1 receptors on the cell surface is also not known we assume Plexin-D1 receptors vary within the same range as VEGFR-2 receptors (see ([@bib6]) for details), and are instantly activated by Sema3E when present. These assumptions produce the most parsimonious model possible, permitting Plexin-D1 levels to be controlled by just the D3 time delay parameter, and Sema3E-Plexin-D1 signaling strength to be determined by the modulation of a single parameter *s*, which varies the strength of effect of the signaling on Dll4 up-regulation specifically. Dll4 levels were then determined as follows:

$$Dll4_{t + 1} = \operatorname{}Dll4_{t} + V^{''}\delta - P''s$$

where $V''$ is the number of active VEGFR-2 receptors by VEGF after time delay D1 has been applied, representing the current active VEGFR-2 level affecting gene expression in the nucleus. Likewise $P''$ is the number of Plexin-D1 receptors (assumed activated by Sema3E) able to affect gene expression after time delay D4.

Calibrating Dll4 regulation parameters $\delta,s$ {#s2-7}
-------------------------------------------------

Previously δ, which represents the up-regulation strength of Dll4 by VEGF-VEGFR-2 signaling, was calibrated to 2 to generate matching tip/stalk pattern selection and sprouting behavior in vivo under different conditions ([@bib6]; [@bib8]). So now with a balancing inhibition term *s* representing reduction in Dll4 via Plexin-D1, we know that δ - s = 2 is required for normal sprouting. Any combination of δ and *s* values such that this relation held true would give normal sprouting. To simulate loss of Sema3E-Plexin-D1 signaling *s* was set to zero. Thus the value for δ chosen ultimately determines the strength of the simulated Sema3E-Plexin-D1 mutant phenotype, hence results are shown throughout across a range of δ values when s = 0. For control simulations s = δ-2.

Calibrating time delay parameters D3 and D4 {#s2-8}
-------------------------------------------

Experiments indicate that the rate of Plexin-D1 up-regulation by pVEGFR-2 is fast compared to pVEGFR-2 up-regulation of Dll4, indicating that together the delays D3+D4 \>=D1. To investigate the effects of varying the temporal regulation of Plexin-D1 on tip cell selection a sensitivity analysis was performed simulating with different delay settings for the new parameters D3 and D4 (a full analysis of varying delays D1 and D2 is given in \[[@bib6]\]). It was found that the lateral inhibition mechanism is strictly sensitive to the values of these new delay parameters relative to the existing delays D1 and D1. In the model, only a setting of D3+D4 =D1 would allow for normal tip cell selection in control conditions ([Video 1](#media1){ref-type="other"}). Even a delay with D3 or D4 = ± 1 timestep in the model (representing 15 s) would disrupt the process and tip cells could not be selected and the system falls into unrealistic \'flashing\' oscillations as the cells instantly raise and then lower dll4 each time step through the Notch/VEGF negative feedback loop resulting in a counter intuitive hypersprouting rather than inhibited phenotype as no cell is under the inhibition long enough to become a stalk cell ([Video 2](#media2){ref-type="other"}, [3](#media3){ref-type="other"}). Interestingly if all delay parameters are set to zero, representing the null hypothesis that no time delays are required to explain the phenotype, the same system behavior occurs as in [Video 2](#media2){ref-type="other"} and [3](#media3){ref-type="other"} illustrating the importance of explicitly representing the amount of time that gene expression takes in computational models.

Calibrating the degradation rate *r3* {#s2-9}
-------------------------------------

Disrupting the degradation rate *r3* of Plexin-D1 was also found to have drastic affects on the ability of the system to select tip cells. The *r3* parameter was required to satisfy: *r3 = r2 = r1 = 1* timestep (representing 15 s). Any increase led to similar irregular flashing oscillations and abrogated tip cell selection as seen with increases to the delays D3 or D4 ([Video 4](#media4){ref-type="other"} and [5](#media5){ref-type="other"}). Thus for all simulations D3+D4 =D1, where D3= 1 and D4 = 27 timesteps.

Mosaic vessel simulations {#s2-10}
-------------------------

Mosaic vessels follow the same simulation method as simulations of a fully wildtype or mutant vessel, except that at the start of the simulation each cell is randomly assigned a wildtype or mutant setting of the δ and s parameters ([Video 8](#media8){ref-type="other"}). 45% mosaicism was calculated as average of simulations with 40% and 50% mosaicism. Results were averaged over 50 runs.

The \'MSM-CPM\' model {#s2-11}
---------------------

In this model a cell can move within the adhered collective of the sprout powered by multiple local junctional adhesion movements (based on the Cellular Potts Model \'CPM\' of differential adhesion \[[@bib15]\]), which are regulated by VEGF/Notch signaling.

Computational method used for vascular network analysis {#s2-12}
-------------------------------------------------------

The stacks were processed and analyzed in 3D using the following Python 2.7 modules: Numpy, Scipy, Matplotlib, Opencv2, Igraph and Networkx.

The first step of the algorithm was to apply a Gaussian smoothing filter to the stacks. A standard deviation of 5 µm was used for the Gaussian kernel. Next, the moment-preserving threshold technique ([@bib32]) was used in order to find a proper threshold for stack binarization. Pixels having intensity values larger than the calculated threshold were classified as belonging to a vessel. Remaining image components([@bib30]) smaller than 20000 µm^3^ were considered background noise and removed from the binary image. A thinning procedure ([@bib27]) was then applied to the binary image, resulting in what we call the skeleton ([@bib11]) of the blood vessels. The skeleton tends to present some sets of connected pixels having more than two neighbors each. Such sets were erased from the skeleton and represented as a single pixel at the center of mass of the set. The remaining skeleton pixels having at least three neighbors were classified as branching points, while pixels having one neighbor were considered a termination point.

Spurious skeleton segments were removed by an iterative algorithm. First, termination segments smaller than 20 µm were erased, where a termination segment is defined as a segment having one termination point. After erasing such segments, new small termination segments might appear. They were iteratively erased until no new termination segments smaller than 20 µm remained. The sample was then characterized by quantification of the remaining branching points. Finally, in order to validate the analysis, we created images containing both the original image and the final skeletons and verified that the obtained skeletons were accurately representing the original blood vessel structure. Statistical significance was tested using a permutation test with shuffled genotypes.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your manuscript \"Temporal modulation of collective cell behavior controls vascular network topology\" as a Short Report to *eLife*. Three experts reviewed your manuscript, and their assessments, together with my own (Jeremy Nathans, Reviewing Editor), form the basis of this letter. The process was overseen by Janet Rossant as Senior Editor.

As you will see, all of the reviewers were impressed with the importance and novelty of your work. We look forward to receiving the revised version of your manuscript.

I am including the three reviews (lightly edited) at the end of this letter, as there are several specific and useful suggestions in them.

Reviewer \#1:

In this manuscript, Kur et al. describe the use of an improved computational modeling in combination with ex vivo time-lapse microscopy to identify the role of Sema3E/Plexin-D1 in the dynamic selection of tip cells in the developing vasculature. According to the suggested model, inhibition of Dll4 expression due to Plexin-D1 activation by Sema3E result in reduced lateral inhibition of tip cell phenotype in neighboring stalk cells. This, in turn, results in more tip cell selection and more complex vasculature development. To support the model, the authors use two experimental systems. First, they observed that in a *Plxnd1* mosaic vasculature, *Plxnd1^-/-^* endothelial cells are significantly more likely to assume tip cell phenotype, as the model predicts for the case of reduced Dll4 inhibition. Second, they use lung explant to monitor the dynamics of endothelial sprout development in the presence or absence of Plexin-D1 signaling. As the model predicts, in the absence of Plexin-D1 signaling (in *Plxnd1^-/-^* lungs) the authors observe reduced rate of tip cell selection that result in less elaborate endothelial network development.

This is a very interesting manuscript and it is well written. It provides an excellent description of the dynamic of endothelial tip cell selection.

Below are some notes that may help improve the manuscript.

1\) The model depicted in [Figure 1B](#fig1){ref-type="fig"} is lacking at least one major component. The underdeveloped vasculature observed in the *Sema3e^-/-^* or the *Plxnd1^-/-^* mouse retina will result in local hypoxia and thus increase in VEGF production by the surrounding tissue. This is likely to increase Dll4 expression in \"stalk\" cells and inhibition of tip cell selection irrespective of the status of Plexin-D1 activation.

2\) The authors make excellent use of the time-lapse microscopy of lung explants to monitor the dynamics of tip cell selections. The cultures, however, could be better characterized. First, IHC for Plexn-D1 should be performed to show that the sprouting endothelial cells express the receptor. Second, IHC for Dll4 should be performed to show potential differential expression of Dll4 by tip cells, as the model predicts. Third, it is not clear how Sema3E signaling functions in the explant system. Supposedly the tissue surrounding the endothelial cells expresses Sema3E but these cells sprout to a considerable distance from the explant. Is there enough Sema3E secreted to the medium for signaling? Could manipulation of the concentration of Sema3E (either addition of Sema3E to the medium or use of neutralizing antibodies) affect the sprouting endothelial cell behavior? Forth, it is worth mentioning that in the explant, in contrast to the in vivo situation, there is, most likely, no gradient of VEGF signaling since the media is supplemented with VEGF.

3\) A minor point: in the text the authors state that the lung explants were cultured in VEGF-conditioned medium while according to the Materials and methods section recombinant human VEGF was added to the medium.

4\) [Figure 2D](#fig2){ref-type="fig"}, replace chimera with mosaic. These terms are, not interchangeable. A chimera is made of cells from two different individuals.

Reviewer \#2:

This is a well written, interesting paper about the regulation of vascular network density, an important yet poorly understood process. In this collaborative work between the Gu and Bentley labs, each offering unique expertise in experimental and computational modeling studies, the authors report that temporal regulation of the VEGF/Notch feedback loop is key to determining vascular density. Namely, they find that the rate of tip-cell selection dictates network density. More specifically, they manipulate the Sema3E-Plexin-D1 signaling pathway, which had been previously shown by the Gu lab to regulate developmental angiogenesis, to support their claims.

\[Please note that while I can appreciate the value of the computational studies, I cannot evaluate them critically.\]

The experimental work appears to be sound and [Figures 2](#fig2){ref-type="fig"} (cell autonomy studies) and 4 (live tracking of endothelial cell behavior) represent new and informative data.

The question of whether this paper represents a sufficiently novel concept/set of observations to warrant publication in *eLife* will be more easily addressed once the novelty and quality of the computational studies are critically evaluated.

Reviewer \#3:

To me this is an outstanding manuscript because it is the first time where I have seen computational modeling making a contribution beyond confirming already known experimental evidence. By introducing a signaling time delay the authors have added an additional level of sophistication to their computational model that allows them to explore a mechanism in vitro that is difficult to approach experimentally. Based on this the authors suggest that reduced speed of signaling can explain the vascular phenotype in Sema3E loss of function mice. The manuscript is of exceptional high quality, genuinely original and a joy to read.

My main criticism is that the \"speed of signaling hypothesis\" has not been properly compared to alternative hypotheses. The authors have previously shown that Sema3E has an inhibitory effect on Dll4-Notch signaling. Here they tested how the temporal aspect of that signaling affects vessel development. But it could be argued that the simple inhibitory effect (S) of Plexin-D1 signaling could have a similar effect. So, I wonder whether the outcome of in silico deletion of Plexin-D1 has the same outcome when the D levels are reduced and S is increased (i.e. is the temporal aspect of signaling in the model really needed?). In other words, the authors argue that by taking into account the speed of signaling their model has been improved, but they should compare the new with the old model and show why the new one is better and where the old one falls down.
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Author response

Reviewer \#1:

Below are some notes that may help improve the manuscript.1) The model depicted in [Figure 1B](#fig1){ref-type="fig"} is lacking at least one major component. The underdeveloped vasculature observed in the Sema3e^-/-^or the Plxnd1^-/-^

*mouse retina will result in local hypoxia and thus increase in VEGF production by the surrounding tissue. This is likely to increase Dll4 expression in \"stalk\" cells and inhibition of tip cell selection irrespective of the status of Plexin-D1 activation.*

This is a very interesting suggestion. If we step through and consider it logically however we arrive at the current depiction of the figure being sufficient, though we agree it worth considering carefully. Firstly, the phenotype of a retina with high VEGF is known and previously published (e.g. by ourselves in Bentley K et al. Nature Cell biology 2014). A key element of the high VEGF retinal phenotype is the switch from branching to drastic expansion and widening of the leading edge, which mimics the expansion of abnormal vessels in pathologies with high VEGF, furthermore large patches of over-activated cells can be observed in certain regions (also made clear in Bentley et al. 2008). Therefore, given the phenotype here exhibits no such expansion, no over activated regions and branching, though reduced, continues as normal when initiated we can consider that even if there is an elevation in VEGF it is not sufficiently high to overcome the reduction in activation triggered by Semaphorin/Plexin-D1 loss and so not useful to include in a parsimonious model of the primary factors affecting this phenotype.

2\) The authors make excellent use of the time-lapse microscopy of lung explants to monitor the dynamics of tip cell selections. The cultures, however, could be better characterized. First, IHC for Plexn-D1 should be performed to show that the sprouting endothelial cells express the receptor. Second, IHC for Dll4 should be performed to show potential differential expression of Dll4 by tip cells, as the model predicts. Third, it is not clear how Sema3E signaling functions in the explant system. Supposedly the tissue surrounding the endothelial cells expresses Sema3E but these cells sprout to a considerable distance from the explant. Is there enough Sema3E secreted to the medium for signaling? Could manipulation of the concentration of Sema3E (either addition of Sema3E to the medium or use of neutralizing antibodies) affect the sprouting endothelial cell behavior? Forth, it is worth mentioning that in the explant, in contrast to the in vivo situation, there is, most likely, no gradient of VEGF signaling since the media is supplemented with VEGF.

A\) We performed double immunohistochemistry staining with Plexin-D1 and PECAM antibodies on lung explants and found Plexin-D1 protein in sprouting endothelial cells. We added this result as a new panel in [Figure 4---figure supplement 1E](#fig4s1){ref-type="fig"}) and added figure legend, also modified the eighth paragraph of the main text.

B\) We performed double immunohistochemistry with Dll4 and PECAM antibodies on lung explants. We observed that in Wildtype endothelial sprouts Dll4 level is much higher in the tip cells compared to stalk cells. In the *Plxnd1^-/-^*sprouts we observed more high-Dll4-expressing cells compared to wildtype. These data are shown in [Figure 4---figure supplement 1F](#fig4s1){ref-type="fig"} and added figure legend, also modified the eighth paragraph of the main text.

C\) Since there is no good Sema3E antibody available, it is hard to measure the protein levels in the explants. The reviewer's suggestion of doing live imaging analysis under different concentrations of Sema3E is an excellent one, and we just begin these experiments as part of a future study to dig deeper into the molecular details of Sema3E-Plexin-D1 signaling in this context. Our preliminary data showed that adding Sema3E to the medium resulted in an increased frequency of speed changes. However, to perform these live imaging experiments rigorously with different concentrations of Sema3E and with enough sample size will take a long time, which will be part of the future follow up study.

D). Yes, there is no gradient of VEGF in the medium. We have added a sentence about this in the eighth paragraph of the main text.

3\) A minor point: in the text the authors state that the lung explants were cultured in VEGF-conditioned medium while according to the Materials and methods section recombinant human VEGF was added to the medium.

We thank the reviewer for the comment. Indeed, recombinant human VEGF was added to the medium and we corrected text accordingly (main text, eighth paragraph).

4\) [Figure 2D](#fig2){ref-type="fig"}, replace chimera with mosaic. These terms are, not interchangeable. A chimera is made of cells from two different individuals.

Response: We thank the reviewer for this comment. We have made the change in [Figure 2D](#fig2){ref-type="fig"} according to the reviewer's suggestion.

Reviewer \#3:My main criticism is that the \"speed of signaling hypothesis\" has not been properly compared to alternative hypotheses. The authors have previously shown that Sema3E has an inhibitory effect on Dll4-Notch signaling. Here they tested how the temporal aspect of that signaling affects vessel development. But it could be argued that the simple inhibitory effect (S) of Plexin-D1 signaling could have a similar effect. So, I wonder whether the outcome of in silico deletion of Plexin-D1 has the same outcome when the D levels are reduced and S is increased (i.e. is the temporal aspect of signaling in the model really needed?). In other words, the authors argue that by taking into account the speed of signaling their model has been improved, but they should compare the new with the old model and show why the new one is better and where the old one falls down.

We sincerely thank the reviewer for their supportive comments on the modeling.

To clarify, the original model, as published in Bentley, K. et al. J. Theor. Biol (2008) and Bentley, K. et al. Plos Comp. Biol (2009) and in all subsequent papers, there was actually always a time delay component to gene expression, this isn't a new feature of this study, however re-reading our modeling introduction we understand why it may have come across that it was. Time delays were present in the original model to capture the regulation that VEGF activation has on Dll4 (delay D1 in the original model) and Notch activation has on VEGFR-2 (delay D2) as gene expression takes on the on the order of half an hour to multiple hours and the model time steps represent 15 seconds these need to be included to be true to the biological case. Thus when extending the model here to include Semaphorin-Plexin signaling it was necessary to also include the corresponding time delay parameters (the new ones being D3 and D4) but time delay wasn't a novel feature of this study per se, rather the inclusion of Semaphorin effects on Dll4 was the novelty. Firstly, to help clarify this in the main text we have adjusted the third paragraph. Likewise, we have adjusted the Methods text accordingly.

However, we agree a lot of models do side step the reality of the time delays and simulate gene expression effects as instantaneously felt at the cell surface, and anyway from a theoretical point of view it is certainly interesting to just see what happens when we do remove the time delays, to explore the null hypothesis that the reviewer suggests. So, even though it must be stressed such an assumption could never be a realistic alternative to the proposed model as it is not biologically plausible for gene expression to happen in an instant, we re-simulated the model with gene expression changes occurring instantaneously (removing D1-D4). As suggested by the reviewer, S needs to then be increased to compensate for the accumulation of Dll4 effects over time when time delays are present. The result is that the system behavior looks almost exactly like that in [Video 3](#media3){ref-type="other"}, where the time delays were instead mismatched. In a KO simulation without time delays (where δ is high to account for the high S) the cells flash rapidly between high and then low dll4 levels, as big changes in gene expression occur instantaneously every time step, the cells swing rapidly from strong inhibition to release that inhibition and back (when dll4 is high VEGFR-2 expression drops instantaneously at the next timestep driving an instant drop in Dll4 production at the next timestep which breaks the inhibition and allows the VEGFR-2 receptor levels to rise instantaneously) The negative feedback essentially causes an oscillation with period 1 timestep. The phenotypic result is interesting, as can be seen in [Video 3](#media3){ref-type="other"}, no cell is then continually inhibited so every other timestep extension of filopodia can continue, so the phenotype is counter intuitively one of hypersprouting, rather than inhibition. Therefore, we can reject the null hypothesis that a model without time delays in gene expression could still account for the Plexin KO phenotype, which of course does not hypersprout or hyposprout. To clarify this point the text "Calibrating time delay parameters D3 and D4"has been added to the Methods section on calibrating the time delays.
